No overall survival benefit tied to bilateral oophorectomy

No overall survival benefit tied to bilateral oophorectomy
At no age is there an overall survival benefit associated with bilateral oophorectomy compared with ovarian conservation at the time of hysterectomy for benign disease, according to a study published online March 6 in Obstetrics & Gynecology.

(HealthDay)—At no age is there an overall survival benefit associated with bilateral oophorectomy compared with ovarian conservation at the time of hysterectomy for benign disease, according to a study published online March 6 in Obstetrics & Gynecology.

William H. Parker, M.D., from the John Wayne Cancer Institute in Santa Monica, Calif., and colleagues analyzed data from a prospective cohort study of 30,117 participants in the Nurses' Health Study undergoing hysterectomy for benign disease. in 16,914 patients was compared with ovarian conservation in 13,203 patients.

The researchers found that, over 28 years of follow-up, 16.8 percent of women with hysterectomy and bilateral oophorectomy died from all causes, compared with 13.3 percent of women who had ovarian conservation (hazard ratio, 1.13). There was a lower risk of from ovarian cancer with oophorectomy (four women with oophorectomy versus 44 women with ovarian conservation). Before age 47.5 years, oophorectomy was tied to a lower risk of death from only breast cancer. Bilateral oophorectomy was associated with significantly increased mortality in women who had never used estrogen therapy, but not in past and current users for women younger than age 50 years at the time of . The number needed to harm was eight for all-cause death, 33 for coronary heart disease death, and 50 for lung cancer death, assuming a 35-year lifespan after oophorectomy.

"Bilateral oophorectomy is associated with increased mortality in aged younger than 50 years who never used estrogen therapy and at no age is oophorectomy associated with increased survival," the authors write.

The study was partially supported by Ethicon, a Johnson & Johnson company.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Prophylactic options compared for women with BRCA1/2

date Dec 27, 2012

(HealthDay)—The results of a simulation model suggest that, when quality of life is considered, prophylactic bilateral salpingectomy with delayed oophorectomy may be an acceptable alternative to bilateral ...

Recommended for you

Rotational instrument delivery OK for fetal malposition

date Mar 24, 2015

(HealthDay)—Neonatal outcomes are no worse with rotational instrumental delivery than with cesarean delivery for persistent fetal malposition, according to a study published in the March issue of the American Jo ...

Shoulder dystocia maneuvers not tied to neonatal harm

date Mar 23, 2015

(HealthDay)—A variety of shoulder dystocia maneuvers are not associated with neonatal morbidity after adjusting for duration, according to a study published in the March issue of the American Journal of ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.